A Review of the Botany, Phytochemistry, Traditional Uses, Pharmacology, Toxicology, and Quality Control of the

Overview

Journal Front Pharmacol

Date 2023 Sep 8

PMID 37680711

Authors

Panpan Wang

Zhen Wang

Zhanping Zhang

Huiyan Cao

Lingyang Kong

Wei Ma

Weichao Ren

Affiliations

Soon will be listed here.

Abstract

Astragali Radix (Huangqi) is mainly distributed in the Northern Hemisphere, South America, and Africa and rarely in North America and Oceania. It has long been used as an ethnomedicine in the Russian Federation, Mongolia, Korea, Kazakhstan, and China. It was first recorded in the Shennong Ben Cao Jing and includes the effects of reinforcing healthy qi, dispelling pathogenic factors, promoting diuresis, reducing swelling, activating blood circulation, and dredging collaterals. This review systematically summarizes the botanical characteristics, phytochemistry, traditional uses, pharmacology, and toxicology of Astrag to explore the potential of Huangqi and expand its applications. Data were obtained from databases such as PubMed, CNKI, Wan Fang Data, Baidu Scholar, and Google Scholar. The collected material also includes classic works of Chinese herbal medicine, Chinese Pharmacopoeia, Chinese Medicine Dictionary, and PhD and Master's theses. The pharmacological effects of the isoflavone fraction in Huangqi have been studied extensively; The pharmacological effects of Huangqi isoflavone are mainly reflected in its anti-inflammatory, anti-tumor, anti-oxidant, anti-allergic, and anti-diabetic properties and its ability to treat several related diseases. Additionally, the medicinal uses, chemical composition, pharmacological activity, toxicology, and quality control of Huangqi require further elucidation. Here, we provide a comprehensive review of the botany, phytochemistry, traditional uses, pharmacology, toxicology, and quality control of Astragalus to assist future innovative research and to identify and develop new drugs involving Huangqi.

Citing Articles

Unveiling the Phytochemical Diversity and Bioactivity of : A First Report Integrating Experimental and In Silico Approaches.

Gencer G, Sarikurkcu C, Tepe B Pharmaceuticals (Basel). 2025; 18(1).

PMID: 39861165 PMC: 11768182. DOI: 10.3390/ph18010103.

Phytochemical and Biological Investigations of Crude Extracts of .

Aydemir E, Odabas Kose E, Ozkaya Gul S, Korkut A, Kilit A, Celep M Pharmaceuticals (Basel). 2025; 18(1).

PMID: 39861073 PMC: 11768461. DOI: 10.3390/ph18010010.

, and as Immunomodulators-Molecular Mechanisms and Clinical Effectiveness in Allergic Diseases.

Stefan M Curr Issues Mol Biol. 2024; 46(8):9016-9032.

PMID: 39194750 PMC: 11352820. DOI: 10.3390/cimb46080533.

Effect of astragalus injection on left ventricular remodeling in HFmrEF: a systematic review and meta-analysis.

Han X, Huang L, Li G, Mou X, Cheng C Front Cardiovasc Med. 2024; 11:1374114.

PMID: 39165261 PMC: 11333324. DOI: 10.3389/fcvm.2024.1374114.

Pharmacological effects of Astragalus polysaccharides in treating neurodegenerative diseases.

Shi Y, Ma P Front Pharmacol. 2024; 15:1449101.

PMID: 39156112 PMC: 11327089. DOI: 10.3389/fphar.2024.1449101.

References

Lee H, Lee D, Kang K, Song J, Choi Y . Inhibition of Intracellular ROS Accumulation by Formononetin Attenuates Cisplatin-Mediated Apoptosis in LLC-PK1 Cells. Int J Mol Sci. 2018; 19(3). PMC: 5877674. DOI: 10.3390/ijms19030813. View

Yu L, Zhang Y, Chen Q, He Y, Zhou H, Wan H . Formononetin protects against inflammation associated with cerebral ischemia-reperfusion injury in rats by targeting the JAK2/STAT3 signaling pathway. Biomed Pharmacother. 2022; 149:112836. DOI: 10.1016/j.biopha.2022.112836. View

Un R, Horo I, Masullo M, Falco A, Senol S, Piacente S . Cycloartane and oleanane-type glycosides from Astragalus pennatulus. Fitoterapia. 2016; 109:254-60. DOI: 10.1016/j.fitote.2016.01.015. View

He Z, Wang B . [Isolation and identification of chemical constituents of Astragalus root]. Yao Xue Xue Bao. 1990; 25(9):694-8. View

Hu Y, Zhai W, Tan D, Chen H, Zhang G, Tan X . Uncovering the effects and molecular mechanism of (Fisch.) Bunge and its bioactive ingredients formononetin and calycosin against colon cancer: An integrated approach based on network pharmacology analysis coupled with experimental validation and.... Front Pharmacol. 2023; 14:1111912. PMC: 9899812. DOI: 10.3389/fphar.2023.1111912. View

Yu J, Ji H, Liu A . Alcohol-soluble polysaccharide from Astragalus membranaceus: Preparation, characteristics and antitumor activity. Int J Biol Macromol. 2018; 118(Pt B):2057-2064. DOI: 10.1016/j.ijbiomac.2018.07.073. View

Liang C, Zhou A, Sui C, Huang Z . The effect of formononetin on the proliferation and migration of human umbilical vein endothelial cells and its mechanism. Biomed Pharmacother. 2018; 111:86-90. DOI: 10.1016/j.biopha.2018.12.049. View

Shao B, Xu W, Dai H, Tu P, Li Z, Gao X . A study on the immune receptors for polysaccharides from the roots of Astragalus membranaceus, a Chinese medicinal herb. Biochem Biophys Res Commun. 2004; 320(4):1103-11. DOI: 10.1016/j.bbrc.2004.06.065. View

Zhang J, Liu L, Wang J, Ren B, Zhang L, Li W . Formononetin, an isoflavone from Astragalus membranaceus inhibits proliferation and metastasis of ovarian cancer cells. J Ethnopharmacol. 2018; 221:91-99. DOI: 10.1016/j.jep.2018.04.014. View

10.

Song J, Mo S, Yip Y, Qiao C, Han Q, Xu H . Development of microwave assisted extraction for the simultaneous determination of isoflavonoids and saponins in radix astragali by high performance liquid chromatography. J Sep Sci. 2007; 30(6):819-24. DOI: 10.1002/jssc.200600340. View

11.

Shen D, Xie X, Zhu Z, Yu X, Liu H, Wang H . Screening active components from Yu-ping-feng-san for regulating initiative key factors in allergic sensitization. PLoS One. 2014; 9(9):e107279. PMC: 4157890. DOI: 10.1371/journal.pone.0107279. View

12.

Zhou Y, Liu Q, Liu C, Lin L . Calycosin induces apoptosis in human ovarian cancer SKOV3 cells by activating caspases and Bcl-2 family proteins. Tumour Biol. 2015; 36(7):5333-9. DOI: 10.1007/s13277-015-3194-8. View

13.

Jia C, Hu F, Lu D, Jin H, Lu H, Xue E . Formononetin inhibits IL-1β-induced inflammation in human chondrocytes and slows the progression of osteoarthritis in rat model via the regulation of PTEN/AKT/NF-κB pathway. Int Immunopharmacol. 2022; 113(Pt A):109309. DOI: 10.1016/j.intimp.2022.109309. View

14.

Li X, Guo X, Sha M, Gao W, Li X . Combining network pharmacology with chromatographic fingerprinting and multicomponent quantitative analysis for the quality evaluation of Astragali Radix. Biomed Chromatogr. 2022; 36(4):e5319. DOI: 10.1002/bmc.5319. View

15.

El-Bakoush A, Olajide O . Formononetin inhibits neuroinflammation and increases estrogen receptor beta (ERβ) protein expression in BV2 microglia. Int Immunopharmacol. 2018; 61:325-337. DOI: 10.1016/j.intimp.2018.06.016. View

16.

Gunata M, Parlakpinar H, Acet H . Melatonin: A review of its potential functions and effects on neurological diseases. Rev Neurol (Paris). 2019; 176(3):148-165. DOI: 10.1016/j.neurol.2019.07.025. View

17.

Wang Y, Dong X, Li Z, Wang W, Tian J, Chen J . Downregulated RASD1 and upregulated miR-375 are involved in protective effects of calycosin on cerebral ischemia/reperfusion rats. J Neurol Sci. 2014; 339(1-2):144-8. DOI: 10.1016/j.jns.2014.02.002. View

18.

Qiu G, Tian W, Huan M, Chen J, Fu H . Formononetin exhibits anti-hyperglycemic activity in alloxan-induced type 1 diabetic mice. Exp Biol Med (Maywood). 2016; 242(2):223-230. PMC: 5167112. DOI: 10.1177/1535370216657445. View

19.

Chen G, Hou Y, Li X, Pan R, Zhao D . Sepsis-induced acute lung injury in young rats is relieved by calycosin through inactivating the HMGB1/MyD88/NF-κB pathway and NLRP3 inflammasome. Int Immunopharmacol. 2021; 96:107623. DOI: 10.1016/j.intimp.2021.107623. View

20.

Xin M, Olson E, Bassel-Duby R . Mending broken hearts: cardiac development as a basis for adult heart regeneration and repair. Nat Rev Mol Cell Biol. 2013; 14(8):529-41. PMC: 3757945. DOI: 10.1038/nrm3619. View